Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI

Similar documents
Selection and Combination of Markers for Prediction

Results of Crosswalk Study

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

CNADC NIA ADC Clinical Task Force UDS Neuropsychology Work Group April 2011

AD Prevention Trials: An Industry Perspective

Recent publications using the NACC Database. Lilah Besser

Trail making test A 2,3. Memory Logical memory Story A delayed recall 4,5. Rey auditory verbal learning test (RAVLT) 2,6

AMNESTIC MINIMAL COGNITIVE IMPAIRMENT: BEYOND MEMORY

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME

ORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS

UDS version 3 Summary of major changes to UDS form packets

DATA CORE MEETING. Observational studies in dementia and the MELODEM initiative. V. Shane Pankratz, Ph.D.

Speech perception in individuals with dementia of the Alzheimer s type (DAT) Mitchell S. Sommers Department of Psychology Washington University

Form D1: Clinician Diagnosis

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER

Neuropsychological Evaluation of

La cognizione sociale

Outline. Minority Issues in Aging Research. The Role of Research in the Clinical Setting. Why Participate in Research

Detecting neurocognitive impairment in HIV-infected youth: Are we focusing on the wrong factors?

Mild Cognitive Impairment (MCI)

Migrating from UDS 2.0 to UDS 3.0: Modern psychometric methods. Paul K. Crane, MD MPH Department of Medicine University of Washington

Erin Cullnan Research Assistant, University of Illinois at Chicago

WHI Memory Study (WHIMS) Investigator Data Release Data Preparation Guide April 2014

Fostering open access for Alzheimer s and dementia research: Challenges and the NACC experience

22 nd Alzheimer Europe Conference Changing perceptions, practice and policy Vienna (4-6 October 2012)

Assessing cognition in ELDERLY drivers

Papers recently published using NACC data. Lilah Besser, PhD, MSPH

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E

Neuropsychologic evaluation has played a central role in

CRITICALLY APPRAISED PAPER (CAP)

Multistate Markov chains and their application to the Biologically Resilient Adults in Neurological Studies cohort

Clinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly

Clinical Task Force Update

PPMI Cognitive-Behavioral Working Group. Daniel Weintraub, MD

NACC Minimum Data Set (MDS) Public Data Element Dictionary

A Web-Based Normative Calculator for the Uniform Data Set (UDS) Neuropsychological Test Battery

David A Scott Lis Evered. Department of Anaesthesia and Acute Pain Medicine St Vincent s Hospital, Melbourne University of Melbourne

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.

International Forum on HIV and Rehabilitation Research

Lambros Messinis PhD. Neuropsychology Section, Department of Neurology, University of Patras Medical School

Department of Psychology, Sungkyunkwan University, Seoul, Korea

The role of memory on patients with mild cognitive impairment. Sophia Vardaki, PhD National Technical University of Athens

Supplementary Online Content

Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues

Equating UDS Neuropsychological Tests: 3.0>2.0, 3.0=2.0, 3.0<2.0? Dan Mungas, Ph.D. University of California, Davis

Can aspirin slow cognitive decline and the onset of dementia? The ASPREE study. Mark Nelson on behalf of ASPREE Investigators

Moca test instructions

Neurocognitive Functional Assessment After TAVR: Methodologies and Clinical Importance

Why Cognition Matters: Impact of Cognitive Impairment on Safety and Independent Living Skills

Early Diagnosis of Alzheimer s Disease and MCI via Imaging and Pattern Analysis Methods. Christos Davatzikos, Ph.D.

Psychological factors that influence fall risk: implications for prevention

The National Institute on Aging (NIA) of the National

February 8, Prepared By: Glen M. Doniger, PhD Director of Scientific Development NeuroTrax Corporation

The Quick Dementia Rating System (QDRS): A rapid dementia staging tool

Mild Cognitive Impairment in the General Population: Occurrence and progression to Alzheimer s disease

Healthy Aging 11/10/2011. Frank R. Lin, M.D. Ph.D. Maintaining Physical Mobility & Activity. Keeping Socially Engaged & Active.

Comparing MCI Patients to Healthy Controls using Three ERP Paradigms

LANGUAGE AND COGNITIVE TASKS MOST PREDICTIVE OF MILD COGNITIVE IMPAIRMENT. A Thesis by Brooke Holt

Development and Validation of the Alzheimer s Questionnaire Malek-ahmadi, M.

Service Related Project. Kimberley Keegan

Moving Targets: An Update on Diagnosing Dementia in the Clinic

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

Table e-1. MCI diagnosis criteria used by articles included in AAN MCI guideline. MCI diagnosis criteria used by included articles

Plenary Session 2 Psychometric Assessment. Ralph H B Benedict, PhD, ABPP-CN Professor of Neurology and Psychiatry SUNY Buffalo

NEUROPSYCHOMETRIC TESTS

The Relationship Between Cognitive Functioning and the JNC-8 Guidelines for Hypertension in Older Adults

Table 2B: Summary of Select Screening and Initial Assessment Tools for Vascular Cognitive Impairment in Stroke Patients (Updated 2014)

Analysis of Verbal Fluency Ability in Amnestic and Non-Amnestic Mild Cognitive Impairment

Disclosure statement

Supplementary Online Content

Monitoring Cognitive Functioning: National Survey of Midlife in the United States (MIDUS)

Detection of Mild Cognitive Impairment using Image Differences and Clinical Features

MOS SF-36 health survey (Ware &

biomarker may improve the efficiency of a study, and simulations may help in planning studies Requiring an amyloid-β 1 42 VIEWPOINT Suzanne B Hendrix*

NACC Minimum Data Set (MDS) Data Element Dictionary

Effects of Systematic Neurocognitive Rehabilitation after Moderate to Severe TBI- Results from a Randomized Controlled Trial

AAIC 2018, Chicago, Illinois, US. July 22, 2018

I IADL. See Instrumental activities of daily living (IADL) Idiopathic rapid eye movement sleep behavior disorder (Idiopathic RBD), 136

MILD COGNITIVE IMPAIRMENT: What it is & what to do about it

Mild cognitive impairment A view on grey areas of a grey area diagnosis

Supplementary Online Content

SOCIABLE DELIVERABLE D7.2a Interim Assessment of the SOCIABLE Platform and Services

DSM-5 MAJOR AND MILD NEUROCOGNITIVE DISORDERS (PAGE 602)

NO LOWER COGNITIVE FUNCTIONING IN OLDER ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

NIH Public Access Author Manuscript Arch Neurol. Author manuscript; available in PMC 2009 December 17.

Pain and spina bifida: common, severe and worse with age. Konrad Szymanski, Rosalia Misseri, Mark Cain, Adam T. Hirsh

Damian, Anne Mariam. The University of Arizona.

The combination of cognitive testing and an informant questionnaire in screening for dementia

Preliminary Evidence: Diagnosed Alzheimer s Disease But Not MCI Affects Working Memory Capacity: 0.7 of 2.7 Memory Slots is Lost

Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP)

Clinical and Cognitive Features of DLB. James E. Galvin, MD, MPH Washington University School of Medicine

NIH Public Access Author Manuscript J Int Neuropsychol Soc. Author manuscript; available in PMC 2010 August 12.

A Case of Vascular MCI

REGULAR RESEARCH ARTICLES

Copyright 2002 American Academy of Neurology. Volume 58(8) 23 April 2002 pp

Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis. Background

Neurocognitive and Behavioral Indexes for Identifying the Amnestic Subtypes of Mild Cognitive Impairment

The Influence of Sleep on Cognition in Breast Cancer

Cognitive remediation in Recent Onset Schizophrenia: Results of an effectiveness trial

Neuropsychological Performance in Cannabis Users and Non-Users Following Motivation Manipulation

Transcription:

Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI Sarah Monsell NACC biostatistician smonsell@uw.edu October 6, 2012

Background Neuropsychological batteries used widely Summarized using composite score Advantages: Single summary measure Interpretation Multiple testing Reduces floor and ceiling effects Can detect subtle changes Flexible in composition

Background Current popular method: 1. Standardize tests 2. Average the standardized tests within domain 3. Average the domains to create a single standardized measure Assumes equal performance Optimal in MCI due to AD?

Study objectives 1. In amci, determine each domain s ability to classify clinically significant decline 2. Evaluate accuracy of averaged composite in classifying decline 3. Determine whether composite can be improved by weighting the domains

Steps 1. Define the domains 2. Create domain-specific scores 3. Describe individual domain performance 4. Describe composite score performance 5. Compare results

Step 1: Define cognitive domains Factor analysis of 10 neuropsych tests in UDS UDS subjects with amnestic MCI at initial visit Age 60 Primary language English Non-missing test scores * N=3,616 Identify 4 factors * Maximum (300) assigned for missing Trails B

Factor analysis results Factor loading Test 1 2 3 4 Hypothesized domain Logical Memory IA -Immediate 0.075 0.077 0.071 0.525 Episodic memory Logical Memory IA- Delayed 0.079 0.171 0.041 0.782 Episodic memory Digit Span-Forward 0.129 0.101 0.573 0.058 Working memory Digit Span-Backward 0.211 0.086 0.804 0.078 Working memory Animal Naming 0.223 0.900 0.121 0.091 Language Vegetable Naming 0.198 0.432 0.081 0.206 Language Boston Naming Test 0.359 0.360 0.121 0.162 Language Trail Making Test A 0.738 0.163 0.096 0.054 Executive function Trail Making Test B 0.741 0.179 0.268 0.111 Executive function WAIS-R Digit Symbol 0.701 0.230 0.169 0.090 Executive function

Step 2: Create domain-specific scores Reference group: mean and s.d. of test scores at initial visit from subjects with normal cognition For each test, subtract mean and divide by s.d. Average tests within domain Missing data: 50% of tests within domain missing average available tests >50% missing subject excluded

Sample characteristics Characteristic Statistic* Age (years) 76.2 (7.8) Race: White 85.1% Black 11.1% Asian 1.4% Multiracial 2.0% Other or unknown 0.4% Sex: Female 53.1% Education (years) 15.3 (3.1) Amnestic MCI Domain: Single 54.2% CDR-SB 1.4 (1.1) MMSE 27.2 (2.3) *Sample characteristics are calculated from data observed at the UDS initial visit. Mean and (SD) are presented for continuous measures. Sample percentages are presented for categorical measures.

Step 3: Describe domain performance 4 individual domains Gold standard = decline vs. stayed same Calculate the area under the ROC curve (AUC) Outcome: diagnosis 1 year later (stayed amci vs. declined to primary probable AD dementia) Predictor: domain-specific score at the initial visit Initial visit: Neuropsych tests ~1 year later: amci vs. AD

Status one year later Status N (%) Normal cognition 156 (8%) Impaired not MCI 72 (4%) Amnestic MCI * 1,164 (63%) Non-Amnestic MCI 70 (4%) Probable AD dementia * 286 (15%) Possible AD dementia 69 (4%) Dementia of another etiology 43 (2%) * Used in main analysis

Step 4: Describe composite score performance Averaging method: Predictor: average standardized domain scores at initial visit Domain 1 + Domain 2 + Domain 3 + Domain 4 Outcome: stayed amci vs. declined to AD dementia one year later

Step 4: Describe composite score performance Weighted method: Predictor: weights standardized domain score from initial visit w 1 Domain 1 + w 2 Domain 2 + w 3 Domain 3 + w 4 Domain 4 where w 1 + w 2 + w 3 + w 4 = 1 and Calculated AUC for each combination where: 0 w i 0.5 by 0.05 Chose combination with highest AUC

Step 5: AUC results Predictor AUC (95% CI) * Domains Episodic memory domain.69 (.66 -.72) Language domain.65 (.62 -.69) Working memory domain.54 (.51 -.58) Executive function domain.62 (.59 -.66) Composites Average of domains.69 (.66 -.72) Maximizing AUC **.73 (.70 -.76) * Calculated using DeLong DeLong method ** Weights are (0.50, 0.40, 0.00, 0.10) for standardized episodic memory, language, working memory, and executive function

Summary Episodic memory and language > working memory and executive function as subjects decline from amci to AD dementia Focusing on these domains could lead to more precise measurement of clinical decline Potential for disease-specific composite scores

Words of caution Heterogeneity in clinical expression Generalizability of UDS neuropsych battery Limited in episodic memory No visuospatial test Did not control for age, education, etc. Handling of missing data Selection of weights needs to depend on research goals Cross-sectional vs. longitudinal Clinical progression timeline

Acknowledgments Co-investigators: Kate Hayden, Zheyu Wang, Andrew Zhou, Bud Kukull NACC Intramural Research and Data groups NIA Participants and families No disclosures

NACC is funded by the National Institute on Aging (UO1 AG016976) and located in the Department of Epidemiology at the University of Washington School of Public Health, Walter A. Kukull, PhD, Director. Copyright 2010 University of Washington.